Use the search parameters below to filter talks:

Calendar
Calendar

2013 - IPITA 2013 Congress (Monterey)

Mini-Oral Session 6 on Clinical Islet Transplantation - Engraftment and graft monitoring
26 September 2013  /  11:00 - 12:30

Functional imaging of the pancreatic graft by Positron Emission Tomography

Presenter: Lina Sjoberg, Uppsala, Sweden

- Functional imaging of the pancreatic graft by Positron Emission Tomography

Presenter: Lina Sjoberg, Uppsala, Sweden

Islet transplantation outcomes similar in islet after kidney vs. islet alone in T1D adjusted for disease: results from the Collaborative Islet Transplant Registry (CITR)

Presenter: Rodolfo Alejandro, Miami, United States

- Islet transplantation outcomes similar in islet after kidney vs. islet alone in T1D adjusted for disease: results from the Collaborative Islet Transplant Registry (CITR)

Presenter: Rodolfo Alejandro, Miami, United States

Failure to achieve normal metabolic response with ex vivo electroporation of the human proinsulin gene (p3MTChins) in primary murine hepatocytes for correction of NOD and STZ-induced diabetes.

Presenter: Garrett Roll, San Francisco, United States

- Failure to achieve normal metabolic response with ex vivo electroporation of the human proinsulin gene (p3MTChins) in primary murine hepatocytes for correction of NOD and STZ-induced diabetes.

Presenter: Garrett Roll, San Francisco, United States

Long acting GLP1 therapy in islet transplant recipients

Presenter: Eduardo Moraes Leao Peixoto, Miami, United States

- Long acting GLP1 therapy in islet transplant recipients

Presenter: Eduardo Moraes Leao Peixoto, Miami, United States

Improvement in insulin sensitivity following human islet transplantation for type 1 diabetes: comparison of euglycemic clamp and minimal model approaches

Presenter: Michael Rickels, Philadelphia, United States

- Improvement in insulin sensitivity following human islet transplantation for type 1 diabetes: comparison of euglycemic clamp and minimal model approaches

Presenter: Michael Rickels, Philadelphia, United States

Allogeneic pancreas for islet donor assessment for high islet product transplant rate and donor pancreas utilization in a Phase III clinical trial - A preliminary analysis

Presenter: Joshua Wilhelm, Minneapolis, United States

- Allogeneic pancreas for islet donor assessment for high islet product transplant rate and donor pancreas utilization in a Phase III clinical trial - A preliminary analysis

Presenter: Joshua Wilhelm, Minneapolis, United States

Factors predictive of clinical outcomes following single islet allograft infusion in type 1 diabetes from the Collaborative Islet Transplant Registry

Presenter: Bernhard J. Hering, Minneapolis, United States

- Factors predictive of clinical outcomes following single islet allograft infusion in type 1 diabetes from the Collaborative Islet Transplant Registry

Presenter: Bernhard J. Hering, Minneapolis, United States

Parallel Session 2 on Clinical Autologous Islet Transplantation
25 September 2013  /  11:00 - 12:30

Long term outcomes of Total Pancreatectomy and Islet auto transplantation in Children

Presenter: Srinath Chinnakotla, Minneapolis, United States

- Long term outcomes of Total Pancreatectomy and Islet auto transplantation in Children

Presenter: Srinath Chinnakotla, Minneapolis, United States

Early treatment with etanercept and anakinra prevents islet graft damage in clinical islet autotransplantation

Presenter: Bashoo Naziruddin, Dallas, United States

- Early treatment with etanercept and anakinra prevents islet graft damage in clinical islet autotransplantation

Presenter: Bashoo Naziruddin, Dallas, United States

Alpha cells in intraperitoneal, but not intrahepatic, autoislet transplants function normally during hypoglycemia in humans after total pancreatectomy and islet autotransplantation

Presenter: Melena Bellin, Minneapolis, United States

- Alpha cells in intraperitoneal, but not intrahepatic, autoislet transplants function normally during hypoglycemia in humans after total pancreatectomy and islet autotransplantation

Presenter: Melena Bellin, Minneapolis, United States

Robotic total pancreatectomy with autologous islet transplant: the first 6 cases

Presenter: Rainer W. G. Gruessner, Tucson, United States

- Robotic total pancreatectomy with autologous islet transplant: the first 6 cases

Presenter: Rainer W. G. Gruessner, Tucson, United States

Results from 55 open and robot-assisted pancreatectomies with autologous islet transplantation for the prevention of surgically induced diabetes

Presenter: Horacio Rilo, Tucson, United States

- Results from 55 open and robot-assisted pancreatectomies with autologous islet transplantation for the prevention of surgically induced diabetes

Presenter: Horacio Rilo, Tucson, United States

Parallel Session 3 on Clinical Pancreas Transplantation 1
25 September 2013  /  11:00 - 12:30

The physiologic pancreas transplant : Experience with 58 portal-duodenal drained pancreas transplants

Presenter: Marcelo Perosa, Sao Paulo, Brazil

- The physiologic pancreas transplant : Experience with 58 portal-duodenal drained pancreas transplants

Presenter: Marcelo Perosa, Sao Paulo, Brazil

Portal versus systemic venous drainage of pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients

Presenter: Tereza Havrdova, Prague, Czech Republic

- Portal versus systemic venous drainage of pancreatic graft: the effect on glucose metabolism in pancreas and kidney transplant recipients

Presenter: Tereza Havrdova, Prague, Czech Republic

Outcomes of pancreas transplantation from marginal donors in Japan

Presenter: Toshinori Ito, Suita, Japan

- Outcomes of pancreas transplantation from marginal donors in Japan

Presenter: Toshinori Ito, Suita, Japan

Non-CME Session
27 September 2013  /  12:45 - 13:30

Murine islet isolation using recombinant collagenase of the marine bacterium Grimontia hollisae

Presenter: Naoko Teramura, Ibaraki, Japan

- Murine islet isolation using recombinant collagenase of the marine bacterium Grimontia hollisae

Presenter: Naoko Teramura, Ibaraki, Japan

CLINICAL PORCINE ISLET XENOTRANSPLANTATION UNDER COMPREHENSIVE REGULATION

Presenter: Shinichi Matsumoto, Naruto, Japan

- CLINICAL PORCINE ISLET XENOTRANSPLANTATION UNDER COMPREHENSIVE REGULATION

Presenter: Shinichi Matsumoto, Naruto, Japan

Automated human islet culture with continuous renewal of medium using PRISM technology

Presenter: Geraldine Parnaud, Geneva, Switzerland

- Automated human islet culture with continuous renewal of medium using PRISM technology

Presenter: Geraldine Parnaud, Geneva, Switzerland

Mini-Oral Session 7 on Islet Encapsulation, Immunology and Tolerance
26 September 2013  /  11:00 - 12:30

Tacrolimus inhibits the revascularization of isolated pancreatic islets.

Presenter: Ryuichi Nishimura, Sendai, Japan

- Tacrolimus inhibits the revascularization of isolated pancreatic islets.

Presenter: Ryuichi Nishimura, Sendai, Japan

Co-encapsulation of glucagon-like peptide-1 secreting L cells improves microencapsulated islet function

Presenter: Alan Kerby, London, United Kingdom

- Co-encapsulation of glucagon-like peptide-1 secreting L cells improves microencapsulated islet function

Presenter: Alan Kerby, London, United Kingdom

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi